Home to some of the leading infectious disease research facilities in the world, Seattle has become a hub of innovation, according to a recently-published opinion piece in the Seattle Times.
Cowritten by Ellen Johnson Sirleaf, president of Liberia and Mark Ashida, chairman of the board of the Center for Infectious Disease Research, the piece notes that in addiction to the Center for ID Research, Seattle is home to the Fred Hutchinson Cancer Research Center, the Bill & Melinda Gates Foundation, and PATH.
The piece provides additional voices to the choir of health care officials who are lobbying for more research into emerging infectious diseases like Ebola and tuberculosis. The opinion article also emphasizes the point that as global travel becomes more common, vigilance is key to staying ahead of infectious disease spread.
"With more than 550 organizations in Washington performing pioneering scientific research, this region of the world continues to push the envelope in discovering and creating groundbreaking treatments, vaccines and cures that are critical in combating Ebola, AIDS, tuberculosis, malaria and other infectious diseases that kill millions of people in Liberia, West Africa and around the world every year," according to the opinion piece's authors.
Read the full piece below.
Compassionate individuals in Seattle and around the globe saved millions of lives when Ebola pandemic threatened West Africa. ONE year ago, the world faced the frightening prospect of a global Ebola pandemic that threatened to kill millions of people in West Africa and around the world.